RAGWITEK

Indicated For

short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis

About This Medication

# Merck Patient Assistance Program Patient Guide: How to Get RAGWITEK at Low or No Cost RAGWITEK (Short Ragweed Pollen Allergen Extract) is a prescription sublingual tablet used for **sublingual immunotherapy** to treat short ragweed pollen-induced allergic rhinitis with or without conjunctivitis in adults and children 5 to 65 years of age. This guide explains how the **Merck Patient Assistance Program (PAP)** can provide RAGWITEK **free of charge** to eligible patients facing financial challenges, helping you access this important allergy treatment without high costs. ## About RAGWITEK RAGWITEK is an allergen extract tablet placed under the tongue daily during ragweed season and continued year-round for ongoing benefits. It works by building tolerance to short ragweed pollen, reducing symptoms like sneezing, runny nose, itchy eyes, and nasal congestion. Unlike daily allergy medications, RAGWITEK targets the root cause of the allergy over time. Always follow your doctor's instructions for use, starting several months before ragweed season for best results. Common side effects include mouth itching, throat irritation, and mouth swelling—report severe reactions to your doctor immediately. ## Who Qualifies for the Merck Patient Assistance Program? The Merck PAP offers **free Merck medications**, including RAGWITEK, to U.S. residents (no citizenship required) who meet these key criteria: - **Prescription**: You have a valid prescription for RAGWITEK from a U.S.-licensed healthcare provider. - **Residency**: You live in the U.S. or a U.S. territory. - **Financial Need**: Your household income is generally at or below **400% of the Federal Poverty Level (FPL)**, with specific thresholds and case-by-case exceptions for financial hardship. - **Insurance Status**: You are uninsured, underinsured, or Medicare Part D eligible. Exceptions may apply for financial hardship even if insurance criteria aren't fully met. **Physician involvement is required**—both you and your doctor must complete and sign the application. ## Income Eligibility Breakdown Eligibility is based on **total household income** (before taxes) and household size. The program uses **400% of the FPL** as a guideline, with decisions made case-by-case, including exceptions for hardships like high medical debts or unexpected expenses. Here's a simplified table of approximate annual income thresholds (based on 2026 FPL guidelines; confirm current FPL at the time of application): | Household Size | Maximum Annual Income (400% FPL) | |----------------|---------------------------------| | 1 (Individual) | $60,000 - $75,000 | | 2 (Couple) | $81,000 - $100,000 | | 3 | $102,000 - $125,000 | | 4 | $122,400 - $150,000 | | 5+ | Add ~$20,500 per additional person | **Notes**: These are estimates—actual FPL adjusts yearly. Provide proof of income; the program may verify electronically or review documents. Hardship cases (e.g., job loss, disability) can exceed thresholds. ## Insurance Requirements - **Primary Eligibility**: Best for **uninsured** or **underinsured** patients whose coverage doesn't cover RAGWITEK fully. Medicare Part D patients may qualify if facing high copays. - **Exceptions**: If you have insurance but can't afford it, explain your financial hardship—waivers are possible. - **Exclusions**: Patients with employer plans requiring PAP application as a condition may not qualify. Contact the program at (800) 727-5400 for personalized guidance. ## Step-by-Step Application Process Applying is straightforward with **multiple methods** (mail preferred; phone for help). Expect **2-6 weeks** for processing, though some cases are faster. 1. **Check Eligibility**: Visit merckhelps.com or call (800) 727-5400. Confirm RAGWITEK coverage. 2. **Download the Form**: Get the enrollment form from merckhelps.com. Fill out **Section 1** (your info), sign **Sections 2 & 3** (income authorization—allow electronic verification or attach proof). 3. **Physician Completes Their Part**: Take the form to your doctor. They fill **Sections 4 & 5**, include their NPI number, prescription details, and sign/date. 4. **Gather Required Documents**: - **Proof of Income** (e.g., tax return, pay stubs, W-2, SSI award letter—one document often suffices). - **Proof of Residency** (e.g., utility bill, lease). - **Prescription** (separate for controlled substances; signed by doctor). - **Physician Enrollment** (completed on form). 5. **Submit**: Mail the **original form** (no copies) to Merck PAP. Or fax/call for urgent needs. Phone: (800) 727-5400. 6. **Follow Up**: Track status by phone. Approval means free medication shipped to your **doctor's office or home**. **Tip**: Complete everything accurately— incomplete forms delay processing. ## Timeline and Delivery - **Processing**: Typically **2 weeks** if complete; up to **6 weeks** if more info needed. Urgent? Call for expedited help. - **Delivery**: Free RAGWITEK sent to your doctor's office (they dispense) or your home. Up to **12 months** supply per approval; **reauthorization required** annually or as needed. ## Alternatives if Denied - **Appeal**: Provide more hardship proof and reapply. - **Other Programs**: Check NeedyMeds.org, RxAssist.org, or state programs. No biosimilars for RAGWITEK, but generic allergy options exist. - **Patient Access Network (PAN) Foundation** or **HealthWell Foundation** for copay help if insured. - **Doctor Samples** or **manufacturer coupons** via your provider. - **Generic Alternatives**: Over-the-counter antihistamines or nasal sprays for symptom relief while pursuing immunotherapy. ## Refills and Reauthorization Each approval covers up to 12 months. **Reapply** before expiration—same process, simpler if previously approved. Your doctor must reconfirm need. ## Important Disclaimer This guide is for informational purposes only and based on program details as of March 2026. Eligibility, income limits, and processes can change—always verify with Merck PAP at (800) 727-5400 or merckhelps.com. Not medical advice; consult your doctor for treatment decisions. Merck reserves audit rights and may request more docs. Free medication is not guaranteed.

Program information last verified: March 30, 2026